Vaxxinity, Inc. (OTCMKTS:VAXX – Get Free Report)’s share price passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.01 and traded as low as $0.0010. Vaxxinity shares last traded at $0.0010, with a volume of 219 shares traded.
Vaxxinity Trading Down 90.0%
The stock has a market cap of $12,675.00, a PE ratio of -0.00 and a beta of -71.72. The business’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.01.
Vaxxinity Company Profile
Vaxxinity Inc. is a biotechnology company focused on developing vaccines and immunotherapies for chronic diseases, including neurodegenerative conditions. The company’s approach is designed to stimulate the body’s immune system to target disease-related proteins or pathways, with the goal of addressing underlying disease biology rather than treating symptoms alone. Vaxxinity’s research and development pipeline has included UB-311, an investigational vaccine targeting amyloid beta for Alzheimer’s disease, and UB-312, an investigational vaccine designed to target abnormal alpha-synuclein associated with Parkinson’s disease and other synucleinopathies.
Further Reading
- Five stocks we like better than Vaxxinity
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Vaxxinity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaxxinity and related companies with MarketBeat.com's FREE daily email newsletter.
